# Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

> **NCT01365624** · PHASE1 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Ketorolac tromethamine

## Key facts

- **NCT ID:** NCT01365624
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365624, "Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01365624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*